Acute 0 5 0 5 B-cancer
lymphoblastic 6 19 6 19 I-cancer
leukemia 20 28 20 28 I-cancer
( 29 30 29 30 I-cancer
ALL 30 33 30 33 I-cancer
) 33 34 33 34 I-cancer
receiving 35 44 35 44 O
an 45 47 45 47 O
intensive 48 57 48 57 B-treatment
induction 58 67 58 67 I-treatment
chemotherapy 68 80 68 80 I-treatment
( 81 82 81 82 O
e.g. 82 86 82 86 O
, 86 87 86 87 O
HyperCVAD±R 88 99 88 99 B-treatment
, 99 100 99 100 O
CALGB9251 101 110 101 110 B-treatment
, 110 111 110 111 O
Larsons 112 119 112 119 B-treatment
protocol 120 128 120 128 I-treatment
) 128 129 128 129 O
with 130 134 130 134 O
an 135 137 135 137 O
expected 138 146 138 146 O
duration 147 155 147 155 O
of 156 158 156 158 O
neutropenia 159 170 159 170 B-clinical_variable
of 171 173 171 173 O
≥7 174 176 174 176 O
days 177 181 177 181 I-lower_bound

Age 0 3 182 185 B-age
18 4 6 186 188 B-lower_bound
years 7 12 189 194 I-lower_bound
or 13 15 195 197 O
older 16 21 198 203 O

Allogeneic 0 10 204 214 B-treatment
or 11 13 215 217 I-treatment
autologous 14 24 218 228 I-treatment
HSCT 25 29 229 233 I-treatment
for 30 33 234 237 O
any 34 37 238 241 O
indication 38 48 242 252 O

Expected 0 8 253 261 B-clinical_variable
duration 9 17 262 270 I-clinical_variable
of 18 20 271 273 I-clinical_variable
neutropenia 21 32 274 285 I-clinical_variable
of 33 35 286 288 O
≥ 36 37 289 290 O
7 38 39 291 292 B-lower_bound
days 40 44 293 297 I-lower_bound

Uncontrolled 0 12 298 310 B-chronic_disease
HIV 13 16 311 314 I-chronic_disease
, 16 17 314 315 O
Hepatitis 18 27 316 325 B-chronic_disease
B 28 29 326 327 I-chronic_disease
and 30 33 328 331 I-chronic_disease
C 34 35 332 333 I-chronic_disease
infection 36 45 334 343 I-chronic_disease

Underlying 0 10 344 354 O
diagnosis 11 20 355 364 O
for 21 24 365 368 O
non 25 28 369 372 O
- 28 29 372 373 O
HSCT 29 33 373 377 B-treatment
patients 34 42 378 386 O

Untreated 0 9 387 396 O
major 10 15 397 402 O
infection 16 25 403 412 B-chronic_disease
at 26 28 413 415 O
presentation 29 41 416 428 O

Use 0 3 429 432 O
of 4 6 433 435 O
neutropenic 7 18 436 447 B-treatment
diet 19 23 448 452 I-treatment
within 24 30 453 459 O
72 31 33 460 462 B-upper_bound
hours 34 39 463 468 I-upper_bound
prior 40 45 469 474 I-upper_bound
to 46 48 475 477 O
consent 49 56 478 485 O

Use 0 3 486 489 O
of 4 6 490 492 O
systemic 7 15 493 501 B-treatment
antibacterial 16 29 502 515 I-treatment
antibiotics 30 41 516 527 I-treatment
within 42 48 528 534 O
7 49 50 535 536 B-upper_bound
days 51 55 537 541 I-upper_bound
prior 56 61 542 547 I-upper_bound
to 62 64 548 550 O
initiation 65 75 551 561 O
of 76 78 562 564 O
study 79 84 565 570 O
diet 85 89 571 575 O

patients 0 8 576 584 O
undergoing 9 19 585 595 O
reduced 20 27 596 603 B-treatment
intensity 28 37 604 613 I-treatment
conditioning 38 50 614 626 I-treatment
, 50 51 626 627 O
only 52 56 628 632 O
those 57 62 633 638 O
regimens 63 71 639 647 O
in 72 74 648 650 O
which 75 80 651 656 O
the 81 84 657 660 O
expected 85 93 661 669 O
neutropenia 94 105 670 681 B-clinical_variable
is 106 108 682 684 O
≥ 109 110 685 686 O
7 111 112 687 688 B-lower_bound
days 113 117 689 693 I-lower_bound
are 118 121 694 697 O
permitted 122 131 698 707 O
and 132 135 708 711 O
the 136 139 712 715 O
patient 140 147 716 723 O
must 148 152 724 728 O
reside 153 159 729 735 O
in 160 162 736 738 O
the 163 166 739 742 O
hospital 167 175 743 751 O

